WEBINAR: Bridging the gap: using organ-on-a-chip as an experimental tool to develop (cost) effective therapeutics – Tuesday, 26 September 2023

cnb887 dtr webinar promo bar v1 |
Register here
cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo cn-bio-organ-on-a-chip-logo
  • Products
    • Explore our solutions


      PhysioMimix® products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Liver-on-a-chip model
      • Multi-organ models

      Support packages

      • PhysioMimix® support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix® products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • A guide to pre-validating cells for use in Organ-on-a-chip assays

      • CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

      • CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

      View all news

      Upcoming Events

      • AASLD 2023

      • EUROTOX 2023

      View all events

      Join the team!

      • Content Marketing Manager

      • Senior Scientist R&D

      View all jobs
  • Contact
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

Speak to an expert about 3D validated cells

Enquire

PhysioMimix® consumables

3D validated cells


Accelerate organ-on-a-chip research with 3D validated cells

3d validated cells logo |

Expedite the delivery of human translatable data by eliminating the burden of cell validation.

Pre-validating cells for organ-on-a-chip (OOC) use is frequently overlooked, yet critical to assay success. Use of unvalidated cells results in failed microtissue formation, poor assay performance and unreliable data. The validation process is necessary, but it is also costly and time-consuming.

Sourcing two validated hepatocyte lots for OOC assays costs us around $15K in materials and 100+ hours of a trained scientist’s time.

Our 3D validated cells portfolio eliminates this burden from your laboratory workflow! Choose from our catalog to fast-track the recreation of PhysioMimix OOC models.

3D validated cell features

  • A broad number of individual donors are available
  • High availability of vials per donor
  • Proven metabolic activity, tissue functionality, and 3D growth
  • Guaranteed for culture up to two weeks, maintaining function and phenotype
  • Validated for mono and co-culture assays (see applications section)
  • Tested for use with PhysioMimix OOC Systems and SOPs

Benefits of using 3D validated cells

tick |

Eases your transition into OOC by using cells that are proven to thrive

tick |

Eliminates the burden of in-house quality control testing with convenient, off-the-shelf access

tick |

Delivers reproducible inter-assay performance for data confidence

tick |

Focuses your time on value-add experiments


LifeSciences 2022 |

Cells sourced from LifeNetHealth LifeSciences or Lonza


liver tissue quality |

good / poor liver microtissue

Currently available 3D validated cells*

SourceCells/vialOrder from
Primary human hepatocyte cellsLifeNet Health LifeSciencesmin 5M/vialLifeNet Health LifeSciences
Primary human Kupffer cellsLifeNet Health LifeSciencesmin 500K/vialLifeNet Health LifeSciences
Primary human hepatocyte cellsLonzamin 5M/vialCN Bio
Primary human Kupffer cellsLonzamin 500K/vialCN Bio

*Some geographical regions may have legislation for storing human cells requiring a license

Hepatocyte thawing medium

Hepatocyte thawing medium is not supplied. To maximize post-thaw hepatocyte yield, it is imperative that you purchase hepatocyte thawing medium from the relevant manufacturer.

For LifeNet Health LifeSciences click here

For Lonza click here

The effect of poor lot quality


>60% of the primary human hepatocyte lots tested by our experts in the last five years have failed to form liver microtissues or meet acceptable performance limits in OOC assays.

These brightfield images demonstrate the formation of good (left) and poor (right) liver microtissue formation within the pores of individual Multi-chip Liver-12 plate scaffolds.

Highlighted in the graph is the effect of donor quality on microtissue functionality (albumin production) over 14 days. Eliminate the risk of poor assay performance by using 3D validated cells.

cell quality image |
cell quality graph |
niab report v4 1 |

Validation reports


Our sample reports describe the extensive process of validating donor cells for use in OOC assays. Our quality control procedures ensure that mono-or co-cultures form highly functional, stable three-dimensional liver microtissues.

Primary human hepatocyte monoculture report

Primary human hepatocyte Kupffer cell duo-culture report

Supported applications

To serve a range of different application needs, 3D validated cells can be purchased for mono-or duo-cultures. Tri-cultures are available within NASH-in-a-box kits.

Liver modelCell typeApplicationsRequired products
Mono-culturePrimary human hepatocytesHBV, Drug metabolismPhysioMimix OOC, Liver plates, 3D validated cells
Duo-culturePrimary human hepatocytes + Kupffer CellsHBV, DILI, Immune-mediated toxicityPhysioMimix OOC, Liver plates, 3D validated cells
Tri-culturePrimary human hepatocytes + Kupffer Cells + Stellate CellsNASHPhysioMimix OOC, NASH-in-a-box

Frequently asked questions

Do you supply Safety Data Sheets?

Once ordered, cells are drop-shipped to you directly from the source supplier. Please contact LifeNetHeath LifeSciences or Lonza directly to request any associated materials that are not supplied within the shipment.

How do I order 3D validated cells?

3D validated cells from LifeNet Heath LifeSciences can be ordered directly from LifeNet Heath LifeSciences. Contact us for information about lots that have been validated for use with PhysioMimix OOC Systems.

3D validated Lonza cells must be ordered through CN Bio directly.

Are shipping costs included?

Shipping costs are not included as they may vary depending on the number of vials ordered or split shipment requests. Shipping costs will be added as a line item in any quote requests.

Why did you choose to work with LifeNet Heath LifeSciences and Lonza over other vendors?

LifeNet Health LifeSciences is an innovative leader, trusted collaborator, and reliable solutions provider – with a commitment to providing game-changing innovations in human in vitro biology. They offer the largest selection of comprehensively characterized liver cells and tissue in the industry, including healthy and diseased donor-matched samples. The organization is the only biospecimens provider in the world that spans the donation continuum – from ethical donor consent to protocol-based recovery by highly trained personnel, to tightly controlled transport logistics with minimal ischemia time. Additionally, LifeNet Health LifeSciences also offers a high level of technical support. More information about their commitment to quality can be found here. Discover more about the company at LNHLifeSciences.org. View our joint press release here.

Lonza hepatocyte cells meet the high standard of quality required by organ-on-a-chip systems. With a robust manufacturing process and excellent quality control, state-of-the-art facilities and Lonza’s decades of specialist experience and deep expertise, Lonza cells offer a greater chance of reproducible success. Access to a wide variety of large-sized lots gives customers confidence in ongoing cell availability. View our joint press release here.

Who should I contact with my enquiries?

For anything other than data sheet requests please contact us directly to ensure a streamlined response. Where necessary we will reach out to the responsible supplier.

How should 3D validated cells be stored?

Prior to use, cells should be stored in the vapor phase of liquid nitrogen.

I don’t see the cell type(s) I am interested in within your 3D validated cells catalog

Our development roadmap includes the qualification of additional cell types. When ready these will be added to our catalog of 3D validated cells to facilitate the recreation of other single and multi-organ models in our portfolio. Until available, we can provide you with recommendations based on our experience and/or guidance to validate your own cells prior to their use in OOC assays.
If you are developing your own OOC model, cells are the most critical parameter to consider, validate and quality control. Regardless of the model you are developing, various technical factors should be considered to validate cells for OOC assays. Here are the most important considerations.

  • Decide what type of cells (primary versus iPSC versus immortalized etc.) you want to use
  • Check the number of accessible vials from the vendor to ensure supply
  • Identify the number of cells per vial
  • Test for cell viability (over 80%)
  • How well do they perform in mono- and coculture with other cell types?
  • Do they form 3D tissues with the correct pathophysiology?
  • Are they functional (secreting any functional soluble biomarkers)?
  • Do they behave the way the target organ behaves?
  • Any there clinically relevant endpoints you can use to translate data to the human?

If you do not find the answer to your question listed, please contact us

Featured resources

Posters

FDA Poster Graphic |

Characterization of the effect of primary human hepatocytes (PHH) lots of functions in CN Bio Innovations Liver-Chip using acetaminophen

Blogs

blog lung in crisis |

A guide to pre-validating cells for use in Organ-on-a-chip assays

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Terms | Regulatory | Accessibility

Product Recycling

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • A guide to pre-validating cells for use in Organ-on-a-chip assays September 5, 2023
  • CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems September 5, 2023
  • CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer August 30, 2023

Upcoming events

AASLD 2023 November 10-14, 2023

EUROTOX 2023 September 10-13, 2023